Daniel Souza-Menezes

Cp 486
Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Accuracy of inflammatory biomarkers in assessing outcomes in Chagas disease: a scoping review.

Accuracy of inflammatory biomarkers in assessing outcomes in Chagas disease: a scoping review.

Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene

Published: October 08, 2025

TLR1/2-driven macrophage polarization shapes memory CD4+T-cell responses across the leprosy spectrum.

TLR1/2-driven macrophage polarization shapes memory CD4+T-cell responses across the leprosy spectrum.

Journal: Acta tropica

Published: July 16, 2025

Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection.

Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection.

Journal: Parasitology international

Published: July 02, 2025

Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb/c mice.

Potential immunoprophylactic use of a multi-epitope protein of CD4+ and CD8+ T cells against visceral leishmaniasis in Balb/c mice.

Journal: Research in veterinary science

Published: April 08, 2025

Trypanosoma cruzi trypomastigote infection drives TLR2-NF-κβ-iL-1β axis activation associated with systolic dysfunction in chronic Chagas cardiomyopathy.

Trypanosoma cruzi trypomastigote infection drives TLR2-NF-κβ-iL-1β axis activation associated with systolic dysfunction in chronic Chagas cardiomyopathy.

Journal: Journal of leukocyte biology

Published: March 20, 2025

CD4+TH17 cells play a critical role in conferring resistance to Trypanosoma cruzi infection while also demonstrating potential in mitigating the development of severe cardiac complications.

CD4+TH17 cells play a critical role in conferring resistance to Trypanosoma cruzi infection while also demonstrating potential in mitigating the development of severe cardiac complications.

Journal: Life sciences

Published: March 06, 2025

Improving diagnostic accuracy in visceral leishmaniasis: Chimeric protein-based approach.

Improving diagnostic accuracy in visceral leishmaniasis: Chimeric protein-based approach.

Journal: Diagnostic microbiology and infectious disease

Published: March 05, 2025

Evaluation of the public health laboratory network for tegumentary leishmaniasis in an endemic area of Brazil.

Evaluation of the public health laboratory network for tegumentary leishmaniasis in an endemic area of Brazil.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: August 21, 2024

Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis.

Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis.

Journal: Experimental parasitology

Published: May 10, 2024

CD4+ and CD8+ T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis.

CD4+ and CD8+ T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis.

Journal: Vaccine

Published: March 11, 2024

Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline.

Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: March 06, 2024

Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.

Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.

Journal: Parasitology research

Published: June 20, 2023

Showing 1-12 of 86

Last Updated: 09/26/2026